Published
Molecular Mechanisms In the Pathogenesis of Diabetic Nephropathy: Historical Development, Intracellular Signalling Pathways, Molecular Targets and Contemporary Therapeutic Strategies
Published in November 2026 Issue 11 (Vol. 14, Issue 11, 2026)

Keywords
Abstract
Diabetic nephropathy (DN), increasingly described within the broader clinical framework of diabetic kidney disease (DKD), represents a major microvascular complication of diabetes mellitus and a leading contributor to chronic kidney disease and end-stage kidney failure worldwide. Its pathogenesis involves complex interactions among chronic hyperglycaemia, haemodynamic abnormalities, oxidative stress, inflammatory mediators, mitochondrial dysfunction, endothelial injury, podocyte damage and progressive extracellular matrix accumulation. Historically, the understanding of DN has evolved from morphological descriptions of glomerulosclerosis to the identification of hyperfiltration, renin–angiotensin–aldosterone system activation and multiple intracellular signalling networks. This review examines the historical development and molecular basis of DN, emphasising advanced glycation end-products and receptor for advanced glycation end-products signalling, protein kinase C activation, polyol and hexosamine pathways, transforming growth factor-β/Smad signalling, nuclear factor-κB, mitogen-activated protein kinases, phosphatidylinositol-3-kinase/Akt/mTOR, AMP-activated protein kinase, Nrf2/Keap1, Wnt/β-catenin and NLRP3 inflammasome activation. Particular attention is given to podocyte dysfunction, glomerular endothelial abnormalities, tubular metabolic stress, epigenetic regulation and renal fibrosis. Contemporary therapeutic strategies, including renin–angiotensin system inhibitors, sodium–glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists, are evaluated alongside landmark clinical trials and emerging molecular interventions. The review also discusses integrated treatment approaches, biomarker-based risk stratification and future therapeutic directions. Understanding the convergence of metabolic, haemodynamic and inflammatory pathways is essential for developing individualised, evidence-based interventions capable of delaying renal disease progression and improving long-term cardiorenal outcomes.
Authors (1)
Devansh Mehta
Independent Researcher and Sci...Independent Researcher and Scientific Writer, Meer...Independent Researcher and Scientific Writer, Meerut, Uttar Pradesh, I...Independent Researcher and Scientific Writer, Meerut, Uttar Pradesh, India., 2\. Historical developm...
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
November 2026 Issue 11 (Vol. 14, Issue 11, 2026)Article Impact
Views:1,798
Downloads:942
How to Cite
Mehta, D. (2026). Molecular Mechanisms In the Pathogenesis of Diabetic Nephropathy: Historical Development, Intracellular Signalling Pathways, Molecular Targets and Contemporary Therapeutic Strategies. American Journal of Pharmacy and Health Research, 14(11), 43-73. https://ajphr.com/articles/AJPHR11140004
Article Actions
More from this Issue
In Silico Evaluation of Gossypium Hirsutum Phytoconstituents against Gastric H+/K+-ATPASE
V.P.Rode, Aayush Pandit, ...Read more →
ASSESSMENT OF INTRAVENOUS HIGH-RISK MEDICATION MANAGEMENT IN A TERTIARY CARE HOSPITAL
Rajat Garg, Hemant Bhardw...Read more →
